Synthesis and α-adrenergic activity of 2- and 6-methyl-substituted (3,4-dihydroxyphenyl)-3-piperidinols

European Journal of Medicinal Chemistry

Volumn 32, Issue 3, 1997, Pages 231-240

  Macchia, B ^b   Macchia, M ^b   Martinelli, A ^b   Martinotti, E ^a   Orlandini, E ^b   Romagnoli, F ^b   Scatizzi, R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

3 Piperidinol derivative; Adrenergic stimulating activity; Conformational analysis; Molecular model

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; PIPERIDINE DERIVATIVE; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONFORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; GUINEA PIG; ILEUM; MOLECULAR MODEL; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

EID: 0030936863     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)83974-8     Document Type: Article

References (50)

1. 1 Macchia B, Macchia M, Manera C et al ( 1995) Eur J Med Chem 30, 869-880
2. 2 Bylund DB, Eikenberg DC, Hieble JP et al (1994) Pharmacol Rev 46, 121-136
3. 3 Dixon RAF, Strader CD, Sigal IS (1988) Annual Rep Med Chem 23, 221-233
4. 4 Humlet C, Mirzadegan T (1992) Annual Rep Med Chem 27, 291-300
5. 5 Venter JC, Fraser CM, Kerlavage AR, Buck MA (1989) Biochem Pharmacol 38, 1197-1208
6. 6 Rouvinen J, Pohjala E, Vepsäläinen J, Mälkönen P (1990) Drug Design Delivery 5, 281-300
7. 7 Findlay J, Eliopoulos E (1990) Trends Pharmacol Sci 11, 492-499
8. 8 Hibert MF, Trumpp-Kallmeyer S, Bruinvels A, Hoflack J (1991) Mol Pharmacol 40, 8-15
9. 9 Harrison JK, Pearson WR, Lynch KR (1991) Trends Pharmacol Sci 12, 62-67
10. 10 Trumpp-Kallmeyer S, Hoflack J, Bruinvels A, Hibert M (1992) J Med Chem 35, 3448-3462
11. 11 Strosberg AD, Camoin L, Blin N, Maigret B (1993) Drug Design Discovery 9, 199-211
12. 12 Saunders J (1993) Drug Design Discovery 9, 213-220
13. 13 Rouvinen J, Hoffrén AM, Karjalainen A, Pakkanen TA (1993) Drug Design Discovery 10, 285-295
14. 14 Kontoyianni M, Lybrand TP (1993) Med Chem Res 3, 407-418
15. 15 Hieble JP, Bondinell WE, Ruffolo Jr RR (1995) J Med Chem 38, 3415-3455
16. 16 O'Dowd BF, Brian F, Nguyen T, Tirpak A, Jarvie KR (1990) FEBS Lett 262, 8-12
17. 17 Parmentier M, Libert F, Perret J et al (1993) In: Advances in Second Messenger and Phosphoprotein Research (Brown BL, Dobson PR, eds) Raven Press, New York, USA, 28, 11-18
18. 18 Balsamo A, Crotti P, Macchia B, Macchia F, Del Tacca M, Mazzanti L (1973) Eur J Med Chem 16, 224-227
19. 19 Macchia B, Breschi MC, Gentili D et al (1994) Eur J Med Chem 29, 753-760
20. 20 Macchia B, Balsamo A, Epifani E et al (1986) J Med Chem 29, 740-747
21. 21 Macchia B, Balsamo A, Breschi MC et al (1992) J Med Chem 35, 1009-1018
22. 22 Macchia B, Balsamo A, Breschi MC et al (1993) J Med Chem 36, 3077-3086
23. 23 Ariens EJ (1967) Ann NY Acad Sci 139, 606-631
24. 24 Lands AM, Brown TG (1967) In: Drugs Affecting The Peripheral Nervous System (Burger A, ed) Dekker, New York, USA, chapter 8, 399-472
25. 25 Brittain RT, Jack D, Ritchie AC (1970) Adv Drug Res 5, 197-253
26. 26 Petrongolo C, Tomasi J, Macchia B, Macchia F (1974) J Med Chem 17, 501-507
27. 27 Triggle DJ (1981) In: Adrenergics: Catecholamines and Related Agents Burger's Medicinal Chemistry (Wolff ME, ed) Wiley Interscience, New York, USA, chapter 41, 225-283
28. 28 Albert A (1985) Selective Toxicity: The Physico-Chemical Basis of Therapy. Chapman and Hall, London, UK, chapter 12, 510
29. 29 Hoffman B, Lefkowitz RJ (1990) In: Catecholamines and Sympathomimetic. Drugs The Pharmacological Basis of Therapeutics (Gilman AG, Rall TW, Nies AS, Taylor P, eds) Pergamon Press, New York, USA, chapter 10, 187-220
30. 30 Epifani E, Lapucci A, Macchia B et al (1983) J Med Chem 26, 254-259
31. 31 Paxton K, Amor TA (1977) Acta Cryst B33, 2143-2146
32. 32 Balsamo A, Ceccarelli G, Crotti P, Macchia B, Macchia F, Tognetti P (1982) Eur J Med Chem 17, 471-478
33. 33 Leonard NJ, Ruyle WV (1949) J Am Chem Soc 71, 3094-3098
34. 34 Iorio MA, Gatta F, Michalek H (1980) Eur J Med Chem 15, 165-171
35. 35 Pines SH, Karady S, Sletzinger M (1968) J Org Chem 33, 1758-1761
36. 36 Pizey SS (1974) In: Synthetic Reagents, Ellis Horwood, Chichester, UK, I 323-329
37. 37 Steigman J, Hammett L (1937) J Am Chem Soc 59, 2536-2542
38. 38 Balsamo A, Barili PL, Gagliardi M et al (1982) Eur J Med Chem-Chim Ther 17, 285-289
39. 39 Aaron HS, Ferguson CP (1974) Tetrahedron 30, 803-811
40. 40 Tichy M (1965) In: Advances in Organic Chemistry (Raphael RA, Taylor EC, Winberg H, eds) Interscience, New York, USA, 5, 115
41. 41 Bellamy LJ (1975) In: Advances in Infrared Group Frequencies, Chapman and Hall, London, UK, chapter 8, 273-275
42. 42 Vasickova S, Vitek A, Ticky M (1973) Coll Czech Chem Commun 38, 1917-1803
43. 43 Lyle RE, Thomas JJ (1969) Tetrahedron Lett 897-900
44. 44 Casy AF (1971) PMR Spectroscopy in Medicinal Chemistry and Biological Chemistry, Academic Press London, UK, chapter 4, 139
45. 45 Balsamo A, Lapucci A, Macchia B, Macchia F, Ceserani R, Longiave D (1981) Eur J Med Chem 16, 163-169
46. 46 Insight II Version 2.3, Discover Version 2.9.5, Biosyn Technologies, San Diego, USA
47. 47 Kenakin TP, (1984) Pharmacol Rev 36, 165-222
48. 48 Dauber-Osguthorpe P, Roberts VA, Oaguthorpe DJ, Wolff J, Genest M (1988) Proteins: Structure, Function and Genetics 4, 31-47
49. 49 Macchia B, Balsamo A, Breschi MC et al (1994) J Med Chem 37, 1518-1525
50. 50 De Bernardis JF, Winn M, Arendsen DL, Kerkman DJ, Kyncl JJ (1986) J Med Chem 29, 1413-1417